In Bhattacharjee dataset 24, GATA2 has a lower expression than normal samples in four different LC types: SCLC with a fold change (FC) of -13.297, squamous cell lung carcinoma with a FC of -8.029, lung adenocarcinoma with a FC of -6.027, and lung carcinoid tumor with a FC of -12.984. The gene discussed is GATA2; the disease is laryngotracheoesophageal cleft.